Assessing the utility of in vitro microtubule assays for studying mechanisms of peripheral neuropathy with the microtubule inhibitor class of cancer chemotherapy
Author:
Funder
Genentech
Publisher
Elsevier BV
Subject
Toxicology,General Medicine
Reference47 articles.
1. Targeting microtubules for cancer chemotherapy;Zhou;Curr. Med. Chem. Anti Cancer Agents,2005
2. Macromolecular interaction of halichondrin B analogues eribulin (E7389) and ER-076349 with tubulin by analytical ultracentrifugation;Alday;Biochemistry,2009
3. Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function;Field;Bioorg. Med. Chem.,2014
4. Microtubules as a target for anticancer drugs;Jordan;Nat. Rev. Cancer,2004
5. Drugs that target dynamic microtubules: a new molecular perspective;Stanton;Med. Res. Rev.,2011
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Zwitterionic targeting nanodrugs prepared from poly(propyleneimine) dendrimers for enhanced anti-tumor therapy;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2024-08
2. Combination of microtubule targeting agents with other antineoplastics for cancer treatment;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2022-09
3. Therapeutics for Chemotherapy-Induced Peripheral Neuropathy: Approaches with Natural Compounds from Traditional Eastern Medicine;Pharmaceutics;2022-07-05
4. Efficacy of Crizotinib Combined with Chemotherapy in Treating Advanced Non-Small-Cell Lung Cancer and Effect on Patients’ Quality of Life and Adverse Reaction Rate;Journal of Healthcare Engineering;2022-03-10
5. Clinical and preclinical features of eribulin-related peripheral neuropathy;Experimental Neurology;2022-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3